Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery

Zihao Chen1, Ning Zhang1, Hang Yin Chu2

  • 1School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Insights

Connective tissue growth factor (CTGF) regulates cell growth and wound healing but also contributes to diseases like fibrosis and cancer. Understanding CTGF domains offers new therapeutic targets for drug discovery.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Pathology

Background:

  • Connective tissue growth factor (CTGF) is a crucial signaling molecule.
  • CTGF influences cell proliferation, angiogenesis, wound healing, tumor development, and fibrosis.
  • Its diverse functions are attributed to interactions between its protein domains and other regulatory molecules.

Purpose of the Study:

  • To elucidate the structure and biological functions of CTGF domains under physiological conditions.
  • To summarize CTGF's role in major diseases and identify potential therapeutic targets.
  • To evaluate current CTGF-targeting drugs and propose future aptamer-based inhibitor strategies.

Main Methods:

  • Structural analysis of CTGF domains.
  • Review of literature on CTGF's role in physiological and pathological processes.
  • Analysis of existing CTGF-targeting drugs and aptamer technology.

Main Results:

  • Detailed description of CTGF domain structures and their functions.
  • Identification of key diseases influenced by CTGF, including cancer and fibrosis.
  • Assessment of current drug limitations and potential of aptamer-based inhibitors.

Conclusions:

  • CTGF domain structure and interactions are central to its multifaceted roles.
  • Targeting CTGF offers therapeutic potential for various diseases.
  • Aptamer-based inhibitors represent a promising avenue for next-generation CTGF-targeted therapies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.6K
Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
293
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.6K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
2.7K